Prostate-specific antigen vs. magnetic resonance imaging parameters for assessing oncological outcomes after high intensity-focused ultrasound focal therapy for localized prostate cancer

详细信息    查看全文

• 作者：Louise Dickinson ; M.B.B.S. ; Ph.D.^a ; ^b ; ¹ ; ^{ldickinson@doctors.org.uk} ; Hashim U. Ahmed ; Ph.D. ; F.R.C.S. (Urol)^a ; ^b ; Richard G. Hindley ; F.R.C.S. (Urol)^c ; Neil McCartan ; M.Sc.^a ; Alex Freeman ; F.R.C. Path^d ; Clare Allen ; F.R.C.R.^e ; Mark Emberton ; M.D. ; F.R.C.S. (Urol)^a ; ^b ; Alex P. Kirkham ; F.R.C.R.^e
• 关键词：Focal therapy ; Follow-up ; MRI ; PSA ; HIFU
• 刊名：Urologic Oncology: Seminars and Original Investigations
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：35
• 期：1
• 页码：30.e9-30.e15
• 全文大小：478 K
• 卷排序：35

文摘

There is no validated follow-up method after focal therapy for prostate cancer. Posttreatment MR imaging usefully predicts a negative follow-up biopsy. PSA parameters are less reliable as a follow-up tool.